AllianceBernstein’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

AllianceBernstein’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-17,700	Closed	-$218K	–	3267
2022 Q4	$218K	Buy	17,700 +3,700	+26%	+$88.2K	﹤0.01%	2981
2022 Q3	$459K	Buy	+14,000	New	+$396K	﹤0.01%	2690

AllianceBernstein's CINC Position: Q1 2023 in Review

AllianceBernstein sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 17,700 shares — an estimated $218K sold.

AllianceBernstein first reported a position in CINC in Q3 2022 and held it in 2 quarters. The position peaked at $459K in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

AllianceBernstein reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
AllianceBernstein sold 17,700 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $218K.
AllianceBernstein first reported a position in CinCor Pharma, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
AllianceBernstein's CinCor Pharma, Inc. Common Stock position peaked at $459K in Q3 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on AllianceBernstein's 13F filing for Q1 2023, filed 15 May 2023.